Evaluation of safety and immunogenicity of HNVAC, an MDCK-based H1N1 pandemic influenza vaccine, in Phase I single centre and Phase II/III multi-centre, double-blind, randomized, placebo-controlled, parallel assignment studies

V.H. Basavaraj, G. Sampath, Nagendra R. Hegde, V. Krishna Mohan, Krishna M. Ella
  • Vaccine, July 2014, Elsevier
  • DOI: 10.1016/j.vaccine.2014.05.039
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
Read Publication

http://dx.doi.org/10.1016/j.vaccine.2014.05.039

The following have contributed to this page: Nagendra Hegde